Kim Kardashian reveals she's turned to stem cell therapy
The 44-year-old beauty has taken to social media to share her health journey, revealing that stem cell therapy has helped her to overcome various aches and pains.
Kim wrote on Instagram: "I'm so excited to share with you guys my stem cell journey.
"Two years ago, I tore my shoulder while lifting weights, leaving me in debilitating pain. I tried everything to find relief, then I learned about the potential of stem cell therapy and met Dr. Adeel Khan at Eterna. His team treated my shoulder with Dezawa Muse cells, and the results were immediate. I regained full range of motion, and my shoulder has felt completely normal ever since.
"Encouraged by this success, I recently returned to Dr. Khan to address chronic back pain that I have been suffering with for years. The Muse stem cell treatment was a game-changer once again. I experienced relief right away, and the unbearable pain is finally gone. If you're struggling with back pain, I can't recommend this treatment enough - it's transformed my life when I thought my body was breaking down.
"Of course, everyone is different, and I'm just sharing what has worked for me lately. Definitely do your own homework and talk to medical professionals.
"Since Muse stem cells aren't yet accessible in the US, I had to travel to Mexico to be treated by Dr. Khan's team. I'm deeply grateful for the opportunity and resources to pursue this healing, and I pray the science continues to evolve so more people can benefit. (sic)"
Meanwhile, Kim previously opened up about her struggles with psoriasis, revealing that she suffered a major flare-up before the Met Gala.
Speaking to SHE MD podcast, Kim shared: "It's only this one spot [on my face] that will itch. And it will really, really itch when it does.
"When I started to get a little bit desperate was when it started to cover my face, and there was a spot really close to my eye, and it would just burn a little bit.
"I remember I had the Met Ball coming up that week and it was covering my face."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Perth Now
5 days ago
- Perth Now
Kim Kardashian reveals she's turned to stem cell therapy
Kim Kardashian thought her "body was breaking down" before she turned to stem cell therapy. The 44-year-old beauty has taken to social media to share her health journey, revealing that stem cell therapy has helped her to overcome various aches and pains. Kim wrote on Instagram: "I'm so excited to share with you guys my stem cell journey. "Two years ago, I tore my shoulder while lifting weights, leaving me in debilitating pain. I tried everything to find relief, then I learned about the potential of stem cell therapy and met Dr. Adeel Khan at Eterna. His team treated my shoulder with Dezawa Muse cells, and the results were immediate. I regained full range of motion, and my shoulder has felt completely normal ever since. "Encouraged by this success, I recently returned to Dr. Khan to address chronic back pain that I have been suffering with for years. The Muse stem cell treatment was a game-changer once again. I experienced relief right away, and the unbearable pain is finally gone. If you're struggling with back pain, I can't recommend this treatment enough - it's transformed my life when I thought my body was breaking down. "Of course, everyone is different, and I'm just sharing what has worked for me lately. Definitely do your own homework and talk to medical professionals. "Since Muse stem cells aren't yet accessible in the US, I had to travel to Mexico to be treated by Dr. Khan's team. I'm deeply grateful for the opportunity and resources to pursue this healing, and I pray the science continues to evolve so more people can benefit. (sic)" Meanwhile, Kim previously opened up about her struggles with psoriasis, revealing that she suffered a major flare-up before the Met Gala. Speaking to SHE MD podcast, Kim shared: "It's only this one spot [on my face] that will itch. And it will really, really itch when it does. "When I started to get a little bit desperate was when it started to cover my face, and there was a spot really close to my eye, and it would just burn a little bit. "I remember I had the Met Ball coming up that week and it was covering my face."
The Australian
28-07-2025
- The Australian
Orthocell adds new director, eyes US growth
Experienced corporate leader Michael McNulty will join the board as a non-executive director and chair of audit committee US-based independent non-executive director Dr Ravi Thadhani elevated to lead independent director Former opposition leader and US ambassador Kim Beazley to step down from board for health reasons but will still advise on US and defence matters Special Report:Perth-based regenerative medicine company Orthocell has made a strong addition to its board as it accelerates plans for US commercialisation, appointing highly experienced director Michael McNulty. As Orthocell (ASX:OCC) accelerates plans for US commercialisation of its flagship nerve repair product Remplir following Food & Drug Administration (FDA) approval in April, McNulty joins as a non-executive director and chair of the audit committee from September. The highly experienced exec brings deep governance and financial expertise to support Orthocell's global growth strategy. He is a chartered accountant with extensive experience as a director across listed companies and not-for-profit organisations. And he has served as managing partner of Deloitte's Perth office for more than a decade, and as a board member of both Deloitte Australia and the Deloitte Foundation. McNulty has also held various executive roles, including on Deloitte's national consulting executive, as relationship partner for the WA health team, and as Asia Pacific energy and resources leader. Orthocell said McNulty's expertise as a director and strategic consultant aligns strongly with its mission to expand the commercial roll-out of its innovative regenerative solutions and will play a key role in supporting the company's continued growth. With the new appointment confirmed, the Orthocell board now comprises five directors including four Independent non-executive directors and one executive director. In addition to McNulty's appointment, current US-based independent non-executive director Dr Ravi Thadhani has been elevated to lead independent director. Thadhani will also lead a new committee focused on the US commercialisation of Remplir. The board changes follow the recent appointment of senior executives including Jim Piper as chief financial officer, and Adam Wood to the newly created role of chief commercial officer. The appointments are part of Orthocell's strategy to scale up international commercialisation of its product portfolio, particularly in the US. Beazley's contributions invaluable Chairman John Van Der Wielen said the board and executive team are deeply grateful for Beazley's contributions, which have helped guide Orthocell's global strategy during a key phase in the company's development. He said his significant US experience and deep understanding of advocacy were instrumental in positioning Orthocell as a leader in regenerative medicine and supporting its US expansion. 'I would like to extend our sincere gratitude to Kim Beazley for his contributions to the board,' he said. 'Kim's extensive US experience, garnered from his extraordinary political and diplomatic career and decades of public service, has been pivotal in strengthening Orthocell's international expansion – particularly in the United States, the world's largest healthcare market.' Beazley said it had been a privilege to serve on the board of a company with 'such brilliant products for human relief'. 'I thank the chairman, the CEO, my fellow board members and our wonderful workforce for the superb work they are doing,' he said. 'Orthocell board members need to be able to fully participate in all locations where advocacy is useful or meetings need to take place. 'My circumstances mean I must stand down. As I recover, I look forward to assisting – particularly in the US and with defence applications.' Appointments to help drive expansion strategy Van Der Wielen said he was delighted to welcome McNulty to the board and as chair of the audit committee and see Thadhani become lead independent director. ' significant leadership experience as a director and senior executive across a broad range of industries – particularly healthcare and resources – will greatly complement our board. 'Meanwhile, Dr Ravi Thadhani's elevation to lead independent director will bring enhanced collaboration with a dedicated focus on the US market. 'We look forward to working with Michael and Ravi as we accelerate our global expansion strategy.' As part of his appointment, Orthocell will issue McNulty two million options, in addition to director's fees, with an exercise price of $1.53 and a three-year expiry. The options will vest after two years, subject to McNulty remaining on the board. Orthocell said they do not require shareholder approval as he was not a director at the time of negotiation and had no influence over the decision. This article was developed in collaboration with Orthocell, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Perth Now
09-07-2025
- Perth Now
Olivia Munn reveals her mother is battling breast cancer
Olivia Munn's mother is battling breast cancer. The 45-year-old actress shared the news via Instagram, revealing her mum Kim Munn, 72, was diagnosed with Stage 1 HER2-positive breast cancer – less than a year after Olivia's own diagnosis. In a caption alongside 11 pictures of Kim receiving treatment in hospital, Olivia opened up about the painful experience of watching her mother go through breast cancer, describing it as 'even more heartbreaking' than her own health fight. Olivia was first diagnosed with breast cancer in April 2023 after undergoing a Breast Cancer Lifetime Risk Assessment test. Her results led to further testing and eventually to a double mastectomy. She said on Instagram alongside the snaps of her mum: 'After my own breast cancer diagnosis in 2023, I urged my mother and sister to take the Breast Cancer Lifetime Risk Assessment test. 'My mother scored 26.2 per cent. 'Her yearly mammogram had just come out clear but because of that high score I insisted she get an MRI. Shortly after that MRI, my mother was diagnosed with Stage 1 HER2 breast cancer.' According to Olivia, Kim has since completed 12 rounds of chemotherapy and will continue receiving Herceptin infusions — a targeted therapy drug — through the autumn. The Newsroom star also revealed the emotional toll of seeing her mother go through the illness. 'From my mom being there after my double mastectomy to me being there after hers,' she said. Olivia added: 'From me having to find an oncologist, to my mom and I sharing one. I can tell you this: going through cancer is really hard. 'But there's something about watching a loved one go through it that is even more heartbreaking.' Olivia said she had spent 'many nights' caring for Kim when the effects of chemotherapy became overwhelming. 'It's no small feat to realize you can't do it for them,' she said – adding: 'To anyone out there who is taking care of someone or has made it their profession to do so, thank you. These fights can feel near impossible without you.' In her post, Olivia included photos of herself and Kim at a medical appointment, along with a video of Kim cooking after surgery, a visit from Olivia's husband, John Mulaney, 42, and a throwback image of the two women. The New Girl actress also paid tribute to Kim's spirit and resilience during her treatment. 'I want to say how proud I am of my mom,' Olivia wrote. She added: 'She's handled all of this with bravery and humour while still driving us crazy (just days after her double mastectomy she tried to do laundry and make dinner — she's insane.)' Olivia concluded by sharing resources for early detection, encouraging followers to take the free Tyrer-Cuzick Risk Assessment and to request breast MRIs when appropriate. She added: 'My mom wanted me to tell you that she hopes by sharing her story it will help save someone's life.' Olivia previously kept her diagnosis private, only revealing it in March 2024. 'I went from feeling completely fine one day, to waking up in a hospital bed after a 10-hour surgery the next,' she said at the time. She also thanked John for his support, saying: 'Being there before I went into each surgery and when I woke up, always placing framed photos of our little boy Malcolm so it would be the first thing I saw.'
